跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NUTRIBRIDGE CRYSTOE CAPSULE - NPRA Drug Approval Details
Approvals
/
NPRA
/
NUTRIBRIDGE CRYSTOE CAPSULE
Approved
STANDARD
NUTRIBRIDGE CRYSTOE CAPSULE
NUTRIBRIDGE (MALAYSIA) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 29, 2025
Approval ID
084a89f3ce296c5f
Company
NUTRIBRIDGE (MALAYSIA) SDN. BHD.
Type
Standard
Approval Details
Approval Id
084a89f3ce296c5f
Drug Approval Npra Name
NUTRIBRIDGE CRYSTOE CAPSULE
Product Name
NUTRIBRIDGE CRYSTOE CAPSULE
Registration Number
MAL25086198TC
Holder Company Name
NUTRIBRIDGE (MALAYSIA) SDN. BHD.
Holder Address
NO.1, JALAN 1/152, PB1-2911, TAMAN OUG PARKLANE 58200 MALAYSIA
Holder Phone
01114010766
Manufacturer Company Name
BELIVE HEALTHCARE SDN. BHD.
Manufacturer Address
NO. 1 JALAN PENYAJAK U1/45A TAMAN PERINDUSTRIAN TEMASYA ALPINE, SEKSYEN U1 40150 SHAH ALAM MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL25086198TC
Version
1764410822
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 29, 2025
Approval ID
084a89f3ce296c5f
Type
Standard
Source
Official Source
Back to NPRA Approvals